Healthcare -
Biotechnology - NASDAQ - US
$ 3.475
-5.83 %
$ 295 M
Market Cap
-2.94
P/E
TERN - TOTAL CURRENT LIABILITIES
Total Current Liabilities TERN - Terns Pharmaceuticals, Inc.
11.9 M
LAST VALUE
32.34%
2 YEAR CAGR
38.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR